Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Roswell Park Cancer Institute

Roswell Park Cancer Institute in Buffalo, New York, United States is listed as a site for 1,597 registered clinical trials, 405 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,597
Ongoing 405

This page covers the site record Roswell Park Cancer Institute in Buffalo, New York, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the Roswell Park Cancer Institute report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,597 trials counted.

  • Phase 1 247 trials
  • Phase 1/2 134 trials
  • Phase 2 535 trials
  • Phase 2/3 46 trials
  • Phase 3 399 trials
  • Phase 4 4 trials
  • Not applicable 120 trials
  • Observational 102 trials
  • Expanded access 9 trials
  • Unknown 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 408 trials
  • Completed 902 trials
  • Terminated 242 trials
  • Other 45 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Expanded access, Unknown)

Top of scale: 94

1991: 1 trials (Phase 2 1) 1992: 4 trials (Observational 2, Phase 3 1, Phase 2 1) 1993: 4 trials (Not applicable 1, Phase 3 1, Phase 2 1, Phase 1 1) 1994: 10 trials (Observational 1, Phase 3 6, Phase 2 2, Phase 1/2 1) 1995: 5 trials (Observational 1, Phase 3 1, Phase 2 2, Phase 1/2 1) 1996: 14 trials (Observational 1, Phase 3 8, Phase 2 3, Phase 1 2) 1997: 25 trials (Observational 2, Not applicable 1, Phase 3 8, Phase 2 6, Phase 1/2 3, Phase 1 5) 1998: 37 trials (Observational 4, Not applicable 1, Phase 3 8, Phase 2/3 1, Phase 2 14, Phase 1/2 2, Phase 1 7) 1999: 35 trials (Observational 3, Not applicable 1, Phase 3 14, Phase 2 13, Phase 1 4) 2000: 46 trials (Observational 1, Not applicable 2, Phase 3 16, Phase 2 20, Phase 1/2 1, Phase 1 6) 2001: 44 trials (Not applicable 2, Phase 3 12, Phase 2 22, Phase 1/2 2, Phase 1 6) 2002: 38 trials (Observational 2, Not applicable 3, Phase 3 8, Phase 2/3 1, Phase 2 15, Phase 1/2 1, Phase 1 8) 2003: 45 trials (Observational 4, Not applicable 2, Phase 3 18, Phase 2/3 1, Phase 2 15, Phase 1/2 3, Phase 1 2) 2004: 64 trials (Observational 5, Not applicable 4, Phase 3 19, Phase 2 25, Phase 1/2 5, Phase 1 6) 2005: 42 trials (Observational 5, Not applicable 3, Phase 3 12, Phase 2 15, Phase 1/2 2, Phase 1 5) 2006: 60 trials (Other 1, Observational 7, Not applicable 3, Phase 4 1, Phase 3 16, Phase 2/3 1, Phase 2 23, Phase 1/2 5, Phase 1 3) 2007: 59 trials (Other 1, Not applicable 4, Phase 3 21, Phase 2 20, Phase 1/2 3, Phase 1 10) 2008: 49 trials (Observational 5, Not applicable 2, Phase 3 11, Phase 2/3 2, Phase 2 17, Phase 1/2 5, Phase 1 7) 2009: 61 trials (Observational 4, Not applicable 7, Phase 3 19, Phase 2 15, Phase 1/2 2, Phase 1 14) 2010: 51 trials (Observational 5, Not applicable 5, Phase 3 8, Phase 2/3 2, Phase 2 16, Phase 1/2 7, Phase 1 8) 2011: 49 trials (Observational 7, Not applicable 5, Phase 3 10, Phase 2/3 1, Phase 2 13, Phase 1/2 5, Phase 1 8) 2012: 45 trials (Observational 3, Not applicable 3, Phase 3 7, Phase 2/3 1, Phase 2 15, Phase 1/2 5, Phase 1 11) 2013: 50 trials (Observational 3, Not applicable 5, Phase 3 6, Phase 2/3 1, Phase 2 16, Phase 1/2 7, Phase 1 12) 2014: 64 trials (Observational 2, Not applicable 3, Phase 3 19, Phase 2/3 8, Phase 2 13, Phase 1/2 8, Phase 1 11) 2015: 72 trials (Observational 6, Not applicable 1, Phase 3 17, Phase 2/3 2, Phase 2 28, Phase 1/2 7, Phase 1 11) 2016: 55 trials (Observational 2, Not applicable 6, Phase 3 11, Phase 2/3 1, Phase 2 14, Phase 1/2 10, Phase 1 11) 2017: 94 trials (Observational 5, Not applicable 6, Phase 3 18, Phase 2/3 2, Phase 2 38, Phase 1/2 8, Phase 1 17) 2018: 66 trials (Observational 3, Not applicable 5, Phase 3 18, Phase 2/3 2, Phase 2 24, Phase 1/2 5, Phase 1 9) 2019: 74 trials (Observational 4, Not applicable 11, Phase 3 11, Phase 2/3 2, Phase 2 26, Phase 1/2 5, Phase 1 15) 2020: 50 trials (Observational 5, Not applicable 4, Phase 4 1, Phase 3 11, Phase 2/3 1, Phase 2 15, Phase 1/2 4, Phase 1 9) 2021: 64 trials (Observational 3, Not applicable 4, Phase 3 14, Phase 2/3 4, Phase 2 19, Phase 1/2 11, Phase 1 9) 2022: 37 trials (Observational 2, Not applicable 3, Phase 4 1, Phase 3 6, Phase 2/3 5, Phase 2 12, Phase 1/2 4, Phase 1 4) 2023: 41 trials (Observational 3, Not applicable 6, Phase 3 9, Phase 2/3 4, Phase 2 10, Phase 1/2 5, Phase 1 4) 2024: 48 trials (Not applicable 5, Phase 3 10, Phase 2/3 2, Phase 2 17, Phase 1/2 3, Phase 1 11) 2025: 41 trials (Not applicable 6, Phase 4 1, Phase 3 15, Phase 2/3 2, Phase 2 12, Phase 1 5)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 32
2025 41
2024 48
2023 41
2022 37
2021 64
2020 50
2019 74
2018 66
2017 94

Showing 10 of 36 years.

Start your 14-day trial Email me all 36 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 2 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 1,597 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 206 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 341 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF